Takeshi Takahashi

Director/Board Member at

Pathalys Pharma, Inc.

50 year

Health Technology

Consumer Services

Producer Manufacturing

Profile

Takeshi Takahashi is currently the Director at Pathalys Pharma, Inc. He previously worked as an Independent Director at Mineralys Therapeutics, Inc. from 2020 to 2023.
He also held the position of Co-Chief Operating Officer & Manager-Technology II at Tsugami Corp.
Mr. Takahashi completed his undergraduate degree at Waseda University and holds an MBA from Kellogg School of Management.

Takeshi Takahashi active positions

Companies	Position	Start
Pathalys Pharma, Inc. Pathalys Pharma, Inc. BiotechnologyHealth Technology Operates as late-stage clinical biopharmaceutical company that develops therapeutics for chronic kidney disease	Director/Board Member	-

All active positions of Takeshi Takahashi

Former positions of Takeshi Takahashi

Companies	Position	End
MINERALYS THERAPEUTICS, INC.	Director/Board Member	12/09/2023
TSUGAMI CORPORATION	Chief Operating Officer	-

See the detail of Takeshi Takahashi's experience

Training of Takeshi Takahashi

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Takeshi Takahashi's experience

Linked companies

Private companies	5
Tsugami Corp. Tsugami Corp. Industrial MachineryProducer Manufacturing Engages in the manufacture and sale of precision machine tools	Producer Manufacturing
Waseda University Waseda University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Kellogg School of Management Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Mineralys Therapeutics, Inc. Mineralys Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops medicines to target diseases	Health Technology
Pathalys Pharma, Inc. Pathalys Pharma, Inc. BiotechnologyHealth Technology Operates as late-stage clinical biopharmaceutical company that develops therapeutics for chronic kidney disease	Health Technology